CYP19A1 and breast carcinoma: MCF7 cells over-expressing aromatase (MCF7/Aro) not only mimic in vitro the estrogen dependency of breast cancer, but they also have been shown to be a predictive preclinical model for anti-endocrine therapies in the clinic [37].